Researchers at the BRC and the Francis Crick Institute have highlighted the importance of continued surveillance of emerging SARS-CoV-2 variants and vaccine performance as the virus continues to evolve.
Professor Karl Peggs has been appointed as UCLH director of research and director of the National Institute for Health and Care Research UCLH Biomedical Research Centre.
A cancer treatment that is currently available to only a limited number of UK patients is to be tested at UCLH in a countrywide clinical trial to see if it causes fewer long-term side effects than standard radiotherapy.
A large study looking at the experiences of people across England after giving birth by Caesarean section has highlighted disparities in outcomes between patients of different ethnic groups.
Experts from across the world, led by UCLH and UCL clinicians and scientists, have created a framework to guide the introduction of new and advanced robots for surgical procedures.
Five cases of Alzheimer’s disease are believed to have arisen as a result of medical treatments decades earlier, reports a team of UCL and UCLH researchers.
More people with dementia in the UK will be able to take part in research and help accelerate the development of new treatments, as the Government announces £49.9 million of new funding to build a network of dementia trials sites across the country.
The NHS has become the first healthcare system in the world to provide a new blood group genotyping test which is set to transform care for patients living with sickle cell disorder and thalassaemia.
A new tool developed at UCLH and UCL streamlined recruitment to a clinical trial in intensive care by automatically spotting when a patient met the eligibility criteria for the trial and then alerting the research team.
A potential new drug for patients with multiple myeloma who have failed to respond to several rounds of existing treatments has shown promise in an early phase trial at UCLH.